A ran dom ised, single-blind study to investigate patient-controlled epidural analgesia during labour was conducted using a solution of low-dose bupivacaine-fentanyl. Two groups (n = 25 in each) received a constant infusion supplemented by patient demand boluses, and midwife-administered boluses if required, the size of the infusion and patient increments varying between groups. The quality of analgesia, as assessed by pain scores and patient ratings, was high and participant acceptability very high in both groups. Fourteen per cent of participants were withdrawn due to cephalad extension of block to T5 or supplementary bolus requirements outside the study protocol. Epidural side-effects were not troublesome and drug dose utilisation was low. Significantly greater pain relief (P< 0.04) three hours after commencing patient-controlled epidural analgesia and a trend to fewer women requiring more than two supplementary midwife-administered boluses (P = 0.11) was seen in the group receiving a higher infusion rate. This group used significantly more bupivacaine (P < 0.04) and fentanyl (P < 0.001), but this did not appear to be clinically important with respect to degree of motor block or side-effects. Patient-controlled epidural analgesia appears to be an effective and well accepted method of obstetric analgesia and warrants further investigation.
Some pregnant women in Australia are demanding more active participation in all aspects of obstetric management, including pain relief during labour. I Traditional epidural management with intermittent top-ups can be criticised in that effective analgesia may be interspersed by unpleasant periods of returning pain, especially as delays in midwife or anaesthetist administered topups inevitably occur at times. Secondly, the power to withhold analgesia (especially in the second stage of labour) is held by attending staff. Women in labour can self-administer parenteral opioids to satisfy their needs 2 ,3 and recent advances in pump technology have contributed to a resurgence of interest in patient-controlled analgesia (PCA). In the delivery suite, where epidural analgesia has a respected place and where motivated women may be suffering the worst pain they will ever experience,4 patient-controlled epidural analgesia (PCEA) is an attractive concept. Preliminary °D.R.O.e.G., F.e. Anaes., F.F.A.R.A.e.S., Staff Anaesthetist. studies overseas suggest PCEA is effective, produces high patient satisfaction, and reduces drug utilisation and manpower requirements. [5] [6] [7] [8] It was the purpose of this study to investigate the efficacy and acceptability of PCEA during labour, and to investigate the influence of varying patient weight, when using a constant infusion with patient-controlled bolus method of PCEA.
MATERIALS AND METHODS Fifty-eight women at term with a singleton cephalic fetus, no major obstetric or medical complications and in established labour, were admitted to the study. The study received institutional Research and Ethics Committee approval and informed written consent was obtained by the author or a research midwife once the participant was comfortable (usually following explanation early in labour prior to the onset of severe pain).
A mid-lumbar epidural catheter was inserted by the attending anaesthetist and epidural analgesia established with a 10 ml bolus of bupivacaine 0.125% plus fentanyl 50 mcg via the catheter. An additional 4 ml bolus of bupivacaine 0.5% was administered if necessary at twenty minutes to achieve satisfactory analgesia. Women were then randomly assigned according to a computerderived sequence to commence PCEA with a solution ofbupivacaine 0.125% plus fentanyl 2 mcg per ml, receiving a 4 ml per hr constant infusion plus 4 ml bolus on demand (group 1) or 8 ml per hr infusion plus 3 ml bolus (group 2). A lockout interval of fifteen minutes was selected for both groups so that the maximum available hourly dose of bupivacaine was 25 mg and of fentanyl 40 mcg. Data collection was performed by a research midwife or the author, the patient remaining blind to the size of variables received. A Graseby PCAS device with 50 ml syringe was used and participants were instructed in use of the demand button, and advised to allow 'a few minutes' for each demand increment to take effect. However, it was made clear that there was no limit to the number of demands that could be made and that they could not overdose, as safe limits to drug dose rate had been programmed. Supplementary bolus doses of bupivacaine 20 mg (as 4 ml of O. 5%) were provided by the midwife at the woman's request if at any time she considered her analgesia unsatisfactory, despite activation of the PCA device. However, if more than two such supplements were required, the woman was withdrawn from the study.
Patient characteristics recorded included age, weight, parity, cervical dilatation at epidural insertion, spontaneous versus induced or augmented labour, and public or private health insurance. Blood pressure was monitored halfhourly and five-minutely for twenty minutes after any bolus and hypotension defined as asystolic blood pressure ofless than 100 mmHg or a decrease by 30% from baseline. Fetal heart rate was monitored continuously and women with sensory block cephalad to T6 (as assessed two-hourly) were withdrawn from the study.
The quality of analgesia was assessed by 100 mm visual linear analogue pain scales (VLAPS) prior to and post establishment of epidural analgesia, at two and three hours, then two-hourly, from commencement of PCEA. The study was terminated at spontaneous vaginal delivery or when an obstetric decision was made to intervene and effect delivery (an appropriate epidural top-up being administered by the attending anaesthetist). Within 24 hours of delivery each woman was asked to rate the overall quality of her pain relief during both the first stage of labour and during the expulsion phase while bearing down (if the latter had been attempted), on a four-point scale (0 = unsatisfactory; I = fair; 2 = good; 3 = excellent). She was asked if she considered the technique of PCEA, as used, acceptable. At the end of the first stage of labour the degree of motor block was clinically assessed using a modified Bromage scale of lower limb movement: 0 = able to straight-leg raise bilaterally; I = hip and knee flexion only; 2 = just able to flex knees; 3 = ankle or foot movement only. If she was so motivated, the ability to weight-bear was also assessed. Side-effects recorded at any time from epidural insertion were nausea, shivering, sedation, pruritus and hypotension. Mode of delivery and neonatal Apgar scores were noted, as were PCEA details of duration, demand rate, number of supplementary boluses, and dose rates ofbupivacaine (including supplements but excluding initial establishment doses) and fentanyl (excluding initial dose).
Demographic data and PCEA details are described by mean ± standard deviation (SO) and pain scores by median and interquartile range. Numerical data such as age, weight and cervical dilatation were analysed using t-tests and noncontinuous variables such as side-effects and delivery details using Fisher's exact and chi- 
RESULTS
Fifty-eight women enrolled in this study but eight who delivered within two hours of commencing PCEA were excluded from analyses. The three women who were withdrawn due to high sensory block and the four due to their reqirement for supplementary midwife boluses outside the study protocol (vide infra) had appropriate data included in analyses. All but two women obtained adequate analgesia with the initial bolus of bupivacainefentanyl combination.
Patient characteristics
The groups were well matched for demographic data, pre-epidural pain score, delivery mode and neonatal outcome (Table 1) . Group I (n = 25) Group 2 (n = 25)
Analgesia and PCEA acceptability Four women (all group 1, P = 0.11) were withdrawn from the study after requiring more than two supplementary doses of bupivacaine. Ninety-six per cent of participants considered PCEA an acceptable method of epidural management during labour. Two (both group 1, P = 0.49) did not. On subsequent questioning this was because of dissatisfaction with pain relief rather than dislike of the concept of self-administration.
Pain scores and pain relief indices for the first five hours of PCEA use are shown in Figures 1 and 2. There was a trend at two and three hours for those in group 2 to have lower pain scores and higher pain relief indices, reaching statistical significance for the latter. Analgesia ratings for the two phases of labour are shown in Tables 2 and 3 . There was no significant difference between groups with respect to these ratings or to the mean percentage of pain scores between 0 and 29. Group 1 = --, Group 2 = -. Analgesia in the first stage oflabour was rated good or excellent by 92% of both groups and by 62% and 82% (group 1 and 2 respectively, P = 0.24) during the expulsion phase of labour.
Side-effects and motor block
Groups were not significantly different with respect to side-effects or degree of motor block (Table 4 ). Profound motor block (grade 2/3) occurred in 24% of all women. Ten of seventeen women (59%) who were interested in attempting to weigh-bear were capable of doing so. Three women (one group 1, two group 2) were withdrawn due to high sensory block while using PCEA. There were no pump mishaps.
Details of PCEA
Constant infusion plus patient-controlled boluses of study solution alone provided adequate analgesia for 52% and 44% of groups 1 and 2 respectively. The remaining women required supplementary midwife-administered boluses of stronger solution, four women (8%) requiring more than two such extra supplements of 0.5% bupivacaine 4 ml (20 mg) during PCEA. Details of the duration of PCEA use, drug dose utilisation and demand rate are shown in Table 5 . Of total drug usage, the constant infusion, patient-controlled boluses and midwife-administered boluses Group 1 (n = 13) 4 (31 %) 4(31%) 3 (23%) 2 (15%) Group 2 (n= 17) 6 (35%) 8 (47%) 3 (18%) o contributed 40%, 32% and 28% (group 1); and 65%, 17% and 18% (group 2). DISCUSSION PCEA by demand bolus plus infusion proved to be an effective method of obstetric analgesia in this heterogenous population of labouring women, and was associated with a high rate of acceptability to participants. The incidence of instrumental and caesarean delivery was consistent with the overall rate for all women delivered at this level three obstetric teaching hospital.
Analgesia and acceptability
The quality of analgesia as assessed by pain scores, pain relief indices and women's ratings, was comparable to that achieved using intermittent bolus, regular midwife-administered bolus or continuous infusion epidural analgesia (CIEA)9.14 and consistent with previous studies of PCEA.5,7,8 A low-dose bupivacaine-fentanyl combination proved very effective in both establishing analgesia in early labour and as a solution for PCEA. Such solutions result in more rapid and complete analgesia of longer duration than the equivalent concentration and dose ofbupivacaine alone 13 ,15-17 and reduce drug requirements compared with plain bupivacaine infusions producing equivalent analgesic effect. 9 ,18 In a recent comparison of epidural solutions for PCEA, bupivacaine 0.125% plus fentanyl was considered optimal (compared with bupivacaine plain, with adrenaline, or adrenaline-fentanyl) due to equivalent analgesic efficacy with insignificant side-effects and the lowest bupivacaine dose requirements. 7 Epidural fentanyl-induced pruritus did not require treatment, as previously reported. 7 ,9,13 The neonatal effects of epidural fentanyl boluses up to 100 mcg shortly before delivery are clinically insignificant in the healthy, mature fetus 19 -21 and dose rates up to 50 mcg per hour also appear to be without significant effect. 9 ,13,18 In this study a higher constant-infusion rate appeared to improve analgesic efficacy, in producing a trend to a lower incidence of women who required several extra supplementary boluses, and better pain relief during early PCEA use. Nevertheless, bolus-only PCEA has also proven an effective technique with even lower dose requirements 8 and a comparative study of these two methods of PCEA is warranted.
Acceptance of PCEA in this study was high and the enthusiasm of women to utilise the technique' and their continued enthusiasm having participated was a feature of this study, albeit of course only a subjective impression. This is consistent with a recent randomised, prospective study comparing PCEA with intermittent top-ups which showed a trend to better analgesia and greater satisfaction with PCEA;8 and with a PCEA study in labour in which all 54 participants were willing to use this method of epidural analgesia management again. 7 PCEA, by allowing women to assume some control and responsibility for their pain relief, may offer significant psychological advantages 22 and greater reduction of anxiety compared with other methods.
Motor block and side-effects
Although 0.125% (or less) bupivacaine is considered to produce minimal motor block, supplemented infusions of this solution at dose rates of 20 mg or more per hour result in a high incidence of profound lower limb weakness. 23 -25 In this study a much lower incidence of profound motor block was observed, with no difference between groups despite higher hourly bupivacaine dose rate in those having a larger constant infusion. This may reflect lower bupivacaine dose requirements due to the addition of fentanyl, or differences related to bolus plus infusion management compared with continuous infusion alone. It may be that dense motor block can be further avoided by reducing bupivacaine use with weaker bupivacaine concentrations plus fentanyl, 9, 18 or bolus-only PCEA.8 Further investigation is required.
Bolus administration of bupivacaine 0.125% plus pethidine allows many women to ambulate during labour. 26 In this study, ambulation was not feasible due to non-telemetric continuous fetal heart rate monitoring; however, the majority of those women who attempted to weight-bear for delivery were capable of doing so. A protocol should be established to test this ability during epidural analgesia in order to avoid unexpected collapse due to postural hypotension or muscle weakness.
Side-effects associated with the use of PCEA were infrequent and other than hypotension, did not require treatment. Shivering occurs in 30-50% of labouring women having intermittent top_upS,27-29 but the lower incidence noted in this study is in agreement with reports that shivering is reduced by the addition of epidural opioids to local anaesthetic. 26 ,30,31 Hypotensive episodes are reduced by CIEA compared with intermittent bolus administration and the results in this study compare favourably.9,lO,18 Most episodes were noted at the time of establishment of epidural analgesia. The use of even lower doses of bupivacaine initially may further reduce the incidence of hypotension. 32 Although PCEA bolusplus-infusion appears to be associated with good haemodynamic stability, further investigation of the timing and frequency of hypotensive episodes during PCEA is necessary to rationalise monitoring procedures and perhaps reduce nursing time spent observing blood pressure. Mishaps, due to pump misprogramming, loading and malfunction, have been reported with intravenous PCA,33 but not as yet with PCEA. Three women had cephalad extension of sensory block to the fifth thoracic dermatome. None was symptomatic and all were withdrawn as a precautionary measure. Extension of block to similar levels has previously been described with PCEA using a similar technique. 7
Whether the incidence of this is related to the use of a constant infusion remains to be determined, although more uniform sensory levels appear to occur when a patient-bolusing-only technique is used. 8 Irrespective of the method of epidural management employed in labour, inter-individual variability in epidural spread of solution may lead to cephalad block that is higher than desired. Regular review of the upper dermatome level of block has been advocated, especially when a constant infusion is used. 18 ,23,24,34 In order that maternal and fetal safety is not compromised it is imperative that during PCEA in labour also, nursing and medical staff are well-educated and maintain a high index of suspicion for this and other unwanted events.
PCEA details
Drug dose requirements for both groups were low and consistent with previous studies of PC EA using similar bupivacaine solutions and a bolus plus infusion method. 5 -7 The increased bupivacaine utilisation associated with a higher constant infusion rate was of little clinical significancemotor block was unaffected and accumulative local anaesthetic toxicity does not occur with epidural bupivacaine administered at 10-20 mg/hr. 22 ,35,36 PCEA safety with respect to inadvertent subarachnoid or intravascular injection should be enhanced by the use of low-concentration bupivacaine-fentanyl solutions, small demand boluses and low infusion rates.
Although a higher infusion rate did not alter demand rate, the latter was lower than that reported for bolus plus infusion PCEA with plain 0.125% bupivacaine. 5 This may reflect population differences or the increased duration of effect of bolus doses containing fentanyl. Half the women studied did not require additional supplementary boluses. Methodological differences preclude comparison with other studies, however a recent comparison of bolus plus infusion PCEA and CIEA using 0.125% bupivacaine-fentanyl solution found reduced manpower requirements with respect to the need for attendant-administered supplements in the PCEA groUp. 6 Women in this study needed extra boluses most frequently near or during the second stage of labour. Difficulty in achieving second stage analgesia of comparable quality to first stage has long been recognised with epidural analgesia. 9 ,11 Low-dose bupivacaine-opioid solutions do not remove perineal sensation to the extent of solutions producing dense neural blockade, and a small percentage of women experience distressing delivery pain. 9 ,26 Nevertheless bupivacainefentanyl mixture is more effective than stronger bupivacaine alone in relieving perineal pain during the first stage of labour. 16 When using PCEA with low-dose combinations, provision for additional supplementary boluses of stronger solution should always be made. CONCLUSION PCA for obstetric analgesia was first described in 1970 37 and studies have shown that labouring women are capable of self-administering parenteral opioids to satisfy their needs. 2 ,3 Continued interest in PCA and improvements in pump technology have resulted in the investigation of alternative routes of drug administration, including the epidural route. PCEA, first described for obstetric analgesia in 1988,5 appears an attractive means of allowing motivated women to assume some control and responsibility for their pain relief.
This study has demonstrated that bolus plus infusion PCEA is an effective and acceptable method of epidural management during labour, with few adverse effects and low drug dose requirements. The use of a higher constant infusion rate of 0.125% bupivacaine with fentanyl 2 mcgper ml improved the quality of analgesia slightly without increasing side-effects, with the exception of a statistically significant, but clinically unimportant, increase in drug dose utilisation. Many aspects of PCEA during labour require investigation or re-evaluation; including optimal solutions, methods of PCEA, management practices and large clinical comparisons with established epidural techniques.
PCEA appears to be an important advance in meeting the varying individual desires and needs of women in labour, but must be preceded by patient, nursing and medical staff education, and has the disadvantage of requiring expensive equipment. Further evaluation and assessment of consumer acceptance and interest is awaited.
